The Portuguese government will decide next week whether to replace or reappoint Bank of Portugal Governor Mario Centeno, ...

Announced M&A in EMEA rose 16% in the six months to June but FIG dealmaking surged 48% to $85bn. That made it the busiest ...

Banco do Brasil continues to invest in its digital transformation, with the migration to Windows 11 Enterprise serving as the foundation for a broader shift focused on security, process automation, ...

June 26 (Reuters) - Novo Nordisk (NOVOb.CO) said on Thursday it will collaborate with WeightWatchers to sell its blockbuster weight-loss drug Wegovy, starting July 1.

PORTO, Portugal (AP) — On Porto’s steep streets, several thousands of people celebrated the summer in the way the city has been doing it for decades and centuries: by bonking friends and strangers ...

Novo Nordisk A/S scrapped a partnership with Hims & Hers Health Inc. after less than two months, saying the U.S. company is using 'deceptive marketing' to sell copycat versions of its obesity ...

Portugal tightens naturalisation rules, doubles residency requirement Find out what’s new on ST website and app.

Novo Nordisk said it will stop selling Wegovy on Hims & Hers, claiming the telehealth company sold knockoff versions of the weight-loss drug.

Novo Nordisk has ended its partnership with Hims & Hers Health. The company also released disappointing data from an important trial. The Danish pharmaceutical giant's stock fell after it ...

LONDON/COPENHAGEN (Reuters) -Shares in Novo Nordisk fell as much as 3.5% on Monday after detailed trial data on its experimental obesity drug CagriSema fuelled investor concerns about its ...

Novo Nordisk terminates collaboration with Hims & Hers Health, Inc. due to concerns about their illegal mass compounding and deceptive marketing ...